[1]
|
Kahnert, K., Jörres, R.A., Behr, J. and Welte, T. (2023) The Diagnosis and Treatment of COPD and Its Comorbidities. DÄ International, 120, 434-444. https://doi.org/10.3238/arztebl.m2023.0027
|
[2]
|
Guo, P., Li, R., Piao, T.H., Wang, C.L., et al. (2022) Pathological Mechanism and Targeted Drugs of COPD. The International Journal of Chronic Obstructive Pulmonary Disease, 17, 1565-1575. https://doi.org/10.2147/COPD.S366126
|
[3]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[4]
|
罗晨阳, 何志文. 慢性阻塞性肺疾病与合并症[J]. 结核与肺部疾病杂志, 2023, 4(5): 407-412.
|
[5]
|
Forder, A., Zhuang, R., Souza, V.G.P., et al. (2023) Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer. International Journal of Molecular Sciences, 24, Article No. 2859. https://doi.org/10.3390/ijms24032859
|
[6]
|
Qi, C., Sun, S.-W. and Xiong, X.-Z. (2022) From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis. The International Journal of Chronic Obstructive Pulmonary Disease, 17, 2603-2621. https://doi.org/10.2147/COPD.S380732
|
[7]
|
Sekine, Y., Hata, A., Hiroshima, K., et al. (2014) Lung Carcinogenesis from Chronic Obstructive Pulmonary Disease: Characteristics of Lung Cancer from COPD and Contribution of Signal Transducers and Lung Stem Cells in the Inflammatory Microenvironment. General Thoracic and Cardiovascular Surgery, 62, 415-421. https://doi.org/10.1007/s11748-014-0386-x
|
[8]
|
Uliński, R., Kwiecień, I. and Domagała-Kulawik, J. (2022) Lung Cancer in the Course of COPD-Emerging Problems Today. Cancers, 14, Article No. 3819. https://doi.org/10.3390/cancers14153819
|
[9]
|
Siegfried, J.M. (2022) Sex and Gender Differences in Lung Cancer and Chronic Obstructive Lung Disease. Endocrinology, 163, bqab254. https://doi.org/10.1210/endocr/bqab254
|
[10]
|
Deng, C., Zhang, N., Wang, Y., Jiang, S., et al. (2019) High Systemic Immune-Inflammation Index Predicts Poor Prognosis in Advanced Lung Adenocarcinoma Patients Treated with EGFR-TKIs. Medicine (Baltimore), 98, e16875. https://doi.org/10.1097/MD.0000000000016875
|
[11]
|
Li, Y. and Hecht, S.S. (2022) Carcinogenic Components of Tobacco and Tobacco Smoke: A 2022 Update. Food and Chemical Toxicology, 165, Article ID: 113179. https://doi.org/10.1016/j.fct.2022.113179
|
[12]
|
Wang, M., Zhang, Y., Xu, M., Zhang, H., et al. (2019) Roles of TRPA1 and TRPV1 in Cigarette Smoke-Induced Airway Epithelial Cell Injury Model. Free Radical Biology and Medicine, 134, 229-238. https://doi.org/10.1016/j.freeradbiomed.2019.01.004
|
[13]
|
Xu, L.M., Zhou, L., Yan, C. and Li, L. (2022) Emerging Role of N6-Methyladenosine RNA Methylation in Lung Diseases. Experimental Biology and Medicine, 247, 1862-1872. https://doi.org/10.1177/15353702221128564
|
[14]
|
Nader, C.P., Cidem, A., Verrills, N.M. and Ammit, A.J. (2019) Protein Phosphatase 2A (PP2A): A Key Phosphatase in the Progression of Chronic Obstructive Pulmonary Disease (COPD) to Lung Cancer. Respiratory Research, 20, 222. https://doi.org/10.1186/s12931-019-1192-x
|
[15]
|
Rogers, L.K. and Cismowski, M.J. (2018) Oxidative Stress in the Lung—The Essential Paradox. Current Opinion in Toxicology, 7, 37-43. https://doi.org/10.1016/j.cotox.2017.09.001
|
[16]
|
Yang, I.A., Relan, V., Wright, C.M. et al. (2011) Common Pathogenic Mechanisms and Pathways in the Development of COPD and Lung Cancer. Expert Opinion on Therapeutic Targets, 15, 439-456. https://doi.org/10.1517/14728222.2011.555400
|
[17]
|
Kornum, J.B., Farkas, D.K., Severinsen, M.T., et al. (2019) Cancer Risk and Prognosis after a Hospital Contact for an Elevated Erythrocyte Sedimentation Rate. Cancer Epidemiology, Biomarkers & Prevention, 28, 225-232. https://doi.org/10.1158/1055-9965.EPI-18-0376
|
[18]
|
Xu, J., Cheng, F., Li, Y., Zhang, J., et al. (2021) Erythrocyte Sedimentation Rate Combined with the Probe-to-Bone Test for Fast and Early Diagnosis of Diabetic Foot Osteomyelitis. The International Journal of Lower Extremity Wounds, 20, 227-231. https://doi.org/10.1177/1534734620923278
|
[19]
|
Akkiz, H., Carr, B.I., Bag, H.G., Karaoğullarından, Ü., et al. (2021) Serum Levels of Inflammatory Markers CRP, ESR and Albumin in Relation to Survival for Patients with Hepatocellular Carcinoma. International Journal of Clinical Practice, 75, e13593. https://doi.org/10.1111/ijcp.13593
|
[20]
|
Litao, M.K. and Kamat, D. (2014) Erythrocyte Sedimentation Rate and C-Reactive Protein: How Best to Use Them in Clinical Practice. Pediatric Annals, 43, 417-420. https://doi.org/10.3928/00904481-20140924-10
|
[21]
|
Tekneci, A.K., Akçam, T.İ., Kavurmacı, Ö., Ergönül, A.G., et al. (2022) Relationship between Survival and Erythrocyte Sedimentation Rate in Patients Operated for Lung Cancer. Türk Göğüs Kalp Damar Cerrahisi Dergisi, 30, 381-388. https://doi.org/10.5606/tgkdc.dergisi.2022.21217
|
[22]
|
Platini, H., Ferdinand, E., Kohar, K., Prayogo, S.A., et al. (2022) Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Markers for Advanced Non-Small-Cell Lung Cancer Treated with Immunotherapy: A Systematic Review and Meta-Analysis. Medicina (Kaunas), 58, Article No. 1069. https://doi.org/10.3390/medicina58081069
|
[23]
|
Russo, A., Russano, M., Franchina, T., Migliorino, M.R., et al. (2020) Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study. Advances in Therapy, 37, 1145-1155. https://doi.org/10.1007/s12325-020-01229-w
|
[24]
|
Nøst, T.H., Alcala, K., Urbarova, I., Byrne, K.S., et al. (2021) Systemic Inflammation Markers and Cancer Incidence in the UK Biobank. European Journal of Epidemiology, 36, 841-848. https://doi.org/10.1007/s10654-021-00752-6
|
[25]
|
Xiong, S., Dong, L. and Cheng, L. (2021) Neutrophils in Cancer Carcinogenesis and Metastasis. Journal of Hematology & Oncology, 14, 173. https://doi.org/10.1186/s13045-021-01187-y
|
[26]
|
Tolle, F., Umansky, V., Utikal, J., Kreis, S., et al. (2021) Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies? International Journal of Molecular Sciences, 22, Article No. 6744. https://doi.org/10.3390/ijms22136744
|
[27]
|
Wolf, N.K., Kissiov, D.U. and Raulet, D.H. (2023) Roles of Natural Killer Cells in Immunity to Cancer, and Applications to Immunotherapy. Nature Reviews Immunology, 23, 90-105. https://doi.org/10.1038/s41577-022-00732-1
|
[28]
|
Lang, J., Zhao, Q., He, Y. and Yu, X. (2018) Bone Turnover Markers and Novel Biomarkers in Lung Cancer Bone Metastases. Biomarkers, 23, 518-526. https://doi.org/10.1080/1354750X.2018.1463566
|
[29]
|
Du, W., Guan, H., Wan, X., Zhu, Z., et al. (2023) Circulating Liver Function Markers and the Risk of COPD in the UK Biobank. Frontiers in Endocrinology (Lausanne), 14, Article ID: 1121900. https://doi.org/10.3389/fendo.2023.1121900
|